Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Kardiologia Polska|June 10, 2020
Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac SocietyDariusz A Kosior, Anetta Undas, Grzegorz Kopeć, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 9, 2018
Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b dataHermann Eichler, Pantep Angchaisuksiri, Kaan Kavakli, et al.
Journal of Medicine and Life|June 1, 2022
Expert opinion on current and future prophylaxis therapies aimed at improving protection for people with hemophilia AAngelika Batorova, Ana Boban, Melen Brinza, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2024
Recombinant porcine factor VIII in patients with congenital haemophilia A with inhibitors undergoing surgery: Phase 3, single-arm, open-label studyChristian Pfrepper, Paolo Radossi, Jerzy Windyga, et al.
Ortopedia, Traumatologia, Rehabilitacja|March 26, 2014
Orthopedic procedures in patients with congenital coagulation disorders: single center experienceIreneusz Kotela, Piotr Żbikowski, Paweł Ambroziak, et al.
Przeglad Epidemiologiczny|September 24, 2008
[Prevalence of HCV, HBV and HIV infections among severe Polish haemophiliacs]Jerzy Windyga, Piotr Grabarczyk, Ewa Stefańska, et al.
Journal of Thrombosis and Haemostasis : JTH|December 24, 2023
FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimeticSteven R Lentz, Pratima Chowdary, Lidia Gil, et al.
Thrombosis and Haemostasis|September 28, 2012
Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind studyJerry Powell, Uri Martinowitz, Jerzy Windyga, et al.
Thrombosis and Haemostasis|January 9, 2015
Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) projectKathelijn Fischer, Riita Lassila, Flora Peyvandi, et al.
Thrombosis and Haemostasis|June 1, 2022
Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding DisordersJerzy Windyga, Benoît Guillet, Lucia Rugeri, et al.
Pageof 10